Breast Cancer, Radiation Therapy
Shorter Course of Radiation Therapy For Breast Cancer Is Safe, Will Not Affect Breast Reconstruction, Says Study
A shorter course of post-mastectomy radiation is safe and effective, according to a new study conducted by the University of Utah. Researchers said that cutting treatment time nearly in half - from 25 to 16 sessions - could help make post-mastectomy radiation a more accessible option for patients.
ASTRO: Hypofractionated Radiation Therapy Safe After Breast Reconstruction
For patients undergoing breast reconstruction, a 16-fraction course of hypofractionated postmastectomy radiation therapy (PMRT) is noninferior to a 25-fraction conventional course, according to a study presented at the annual meeting of the American Society for Radiation Oncology (ASTRO),
Shorter course of breast cancer radiation won't impact breast reconstruction
A shorter course of post-mastectomy radiation doesn't jeopardize a patient's chances of successful breast reconstruction, a new study finds.
Shortened radiation therapy proves safe for breast reconstruction after mastectomy
An accelerated course of radiation therapy does not increase complications for patients who undergo breast reconstruction following a mastectomy, new research shows.
Post-mastectomy radiation therapy can be shortened by nearly half for patients planning breast reconstruction
An accelerated course of radiation therapy does not increase complications for patients who undergo breast reconstruction following a mastectomy, new research shows. Findings of the large, Phase III RT CHARM trial (Alliance A221505) were presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Shorter Course of Breast Cancer Radiation Won't Affect Breast Reconstruction
About 40 percent of people with breast cancer have mastectomies, followed by five to six weeks of radiation therapy to kill any cancer cells that may remain in the chest wall or lymph nodes. Most opt for breast reconstruction.
Medscape3h
Full Cognitive Recovery After Brain Radiotherapy Possible for Many Patients
A sizeable proportion of patients with cancer who experience cognitive decline after radiation treatment for brain metastases ...
MedPage Today on MSN20h
Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC
Adding immunotherapy to chemoradiation therapy (CRT) for limited-stage small cell lung cancer (SCLC) failed to improve ...
Daily1d
IMRT and proton therapy offer equally high QoL and tumor control for people with prostate cancer, reports study
People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation ...
Neuroscience News1d
MRI-Guided Radiation Shows Promise for Glioblastoma
MRI-guided radiation, or MRI-linac, can monitor glioblastoma tumor changes in real-time during radiation therapy.
Butler Eagle2d
Radiation may be part of cancer treatment
Communication is key when developing a plan to address and treat breast cancer, or cancer in general. Communication not just ...
BioSpace3d
Novartis’ Lutathera Radiopharma Therapy Improves Survival in Difficult-to-Treat Brain Tumors
Six months after treatment with the radiopharmaceutical therapy, 77.8% of patients with meningioma were alive and had not ...
Targeted Oncology2d
Radiopharmaceuticals and Radiation Therapy for Prostate Cancer Treatment
Savita Dandapani, MD, PhD, discussed combining radium-223 and SBRT for metastatic castration-sensitive prostate cancer.
Medpage Today on MSN2d
Neurocognitive Side Effects of Brain Radiation Subside for Many, Analysis Shows
Patients with brain metastases who experienced cognitive side effects following radiation therapy often fully regain ...